Table 2.
Summary of clinicopathologic features of metastases in cirrhosis
| n (%) unless stated otherwise | |
|---|---|
| Sex | |
| Female | 15 (62.5) |
| Male | 9 (37.5) |
| Age, mean (range) | 64 (47, 78) |
| Laennec Stage | |
| 4A | 10 (41.7) |
| 4B | 7 (29.2) |
| 4 C | 7 (29.2) |
| Primary site | |
| Colorectal | 8 (33) |
| Neuroendocrine | 5 (21) |
| Pancreas | 4 (17) |
| Upper Gastrointestinal | 2 (8) |
| Breast | 2 (8) |
| Mullerian | 1 (4) |
| Lung | 1 (4) |
| Unknown | 1 (4) |
| AST, mean ± SD | 137 ± 200 |
| ALT, mean ± SD | 106 ± 240 |
| Albumin, mean ± SD | 3.2 ± 0.8 |
| Platelets, mean ± SD | 177 ± 89 |
| Cirrhosis-related sequelae | 13 (54.2) |
| Echocardiogram with evidence of shunt | 0 (0) |
| Reversal of portal vein flow | 2 (18.2) |